GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nippon Shinyaku Co Ltd (OTCPK:NPPNY) » Definitions » EV-to-EBIT

Nippon Shinyaku Co (Nippon Shinyaku Co) EV-to-EBIT : 6.33 (As of Apr. 28, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Nippon Shinyaku Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Nippon Shinyaku Co's Enterprise Value is $1,464 Mil. Nippon Shinyaku Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $231 Mil. Therefore, Nippon Shinyaku Co's EV-to-EBIT for today is 6.33.

The historical rank and industry rank for Nippon Shinyaku Co's EV-to-EBIT or its related term are showing as below:

NPPNY' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.63   Med: 21.98   Max: 42.01
Current: 6.88

During the past 13 years, the highest EV-to-EBIT of Nippon Shinyaku Co was 42.01. The lowest was 6.63. And the median was 21.98.

NPPNY's EV-to-EBIT is ranked better than
85.18% of 668 companies
in the Drug Manufacturers industry
Industry Median: 17.12 vs NPPNY: 6.88

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Nippon Shinyaku Co's Enterprise Value for the quarter that ended in Dec. 2023 was $1,852 Mil. Nippon Shinyaku Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $231 Mil. Nippon Shinyaku Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 12.48%.


Nippon Shinyaku Co EV-to-EBIT Historical Data

The historical data trend for Nippon Shinyaku Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nippon Shinyaku Co EV-to-EBIT Chart

Nippon Shinyaku Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.26 23.49 17.91 14.91 10.58

Nippon Shinyaku Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.19 10.58 10.51 11.01 8.23

Competitive Comparison of Nippon Shinyaku Co's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Nippon Shinyaku Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nippon Shinyaku Co's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nippon Shinyaku Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Nippon Shinyaku Co's EV-to-EBIT falls into.



Nippon Shinyaku Co EV-to-EBIT Calculation

Nippon Shinyaku Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1464.274/231.173
=6.33

Nippon Shinyaku Co's current Enterprise Value is $1,464 Mil.
Nippon Shinyaku Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $231 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nippon Shinyaku Co  (OTCPK:NPPNY) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Nippon Shinyaku Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=231.173/1851.95761
=12.48 %

Nippon Shinyaku Co's Enterprise Value for the quarter that ended in Dec. 2023 was $1,852 Mil.
Nippon Shinyaku Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $231 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nippon Shinyaku Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Nippon Shinyaku Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Nippon Shinyaku Co (Nippon Shinyaku Co) Business Description

Traded in Other Exchanges
Address
14, Nishinosho-Monguchi-cho, Kisshoin, Minami-ku, Kyoto, JPN, 601-8550
Nippon Shinyaku Co Ltd is a specialty and generic drug manufacturing company. Nippon's research and development activities include a focus on pharmaceuticals, nutraceuticals, safety and pharmacokinetics of drug seeds, genomic drug discovery, and nucleic acid drugs. The company also develops health food ingredients, preservatives, protein preparations, and spices. Nippon considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Nippon Shinyaku Co (Nippon Shinyaku Co) Headlines

No Headlines